Tapewire

Nasdaq · USD

ABCL

AbCellera Biologics Inc.

Export transactions ↓
Tapewire entity
4118
SEC CIK
0001703057
Parsed reports
142

Last 12 months

Inside the activity.

9 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202510
Dec 202500
Jan 202600
Feb 202630
Mar 202600
Apr 202600
May 202610
Jun 202600
Jul 202600
Aug 202640
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
August 24, 2026 Filed Aug 24, 2026 21:21 UTC PurchaseCommon Shares 53,613 $10.64 $570,442.32
Disclosure

SEC source: 0001628280-26-058684 · wk-form4_1787606506.xml · nonDerivative · entry 1

Hayden Michael R · CIK 0001352908 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 1,373,397

F1 · price: The price reported in Column 4 is a weighted-average price. These shares were acquired in multiple transactions at prices ranging from $10.49 to $10.70. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote.

F2 · ownership.direct: These shares are held by Genworks 2 Consulting, Inc. ("Genworks 2"). The Reporting Person's spouse has sole voting and investment power with respect to the shares held by Genworks 2. The reporting person disclaims beneficial ownership of such securities, except to the extent of his indirect pecuniary interest, if any, therein.

Read SEC document
August 18, 2026 Filed Aug 18, 2026 18:45 UTC PurchaseCommon Shares 10,000 $11.03 $110,300.00
Disclosure

SEC source: 0001834423-26-000008 · wk-form4_1787078721.xml · nonDerivative · entry 1

Montalbano John S. · CIK 0001834423 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 251,000

Read SEC document
August 14, 2026 Filed Aug 14, 2026 16:04 UTC
Booth AndrewChief Financial Officer
PurchaseCommon Shares 37,200 $10.32 $383,904.00
Disclosure

SEC source: 0001834411-26-000008 · wk-form4_1786723463.xml · nonDerivative · entry 1

Booth Andrew · CIK 0001834411 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 482,800

Read SEC document
August 12, 2026 Filed Aug 14, 2026 15:50 UTC PurchaseCommon Shares 46,387 $10.37 $481,033.19
Disclosure

SEC source: 0001628280-26-057007 · wk-form4_1786722614.xml · nonDerivative · entry 1

Hayden Michael R · CIK 0001352908 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 1,319,784

F1 · price: The price reported in Column 4 is a weighted-average price. These shares were acquired in multiple transactions at prices ranging from $10.25 to $10.45. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote.

F2 · ownership.direct: These shares are held by Genworks 2 Consulting, Inc. ("Genworks 2"). The Reporting Person's spouse has sole voting and investment power with respect to the shares held by Genworks 2. The reporting person disclaims beneficial ownership of such securities, except to the extent of his indirect pecuniary interest, if any, therein.

Read SEC document
August 11, 2026 Filed Aug 13, 2026 19:01 UTC GiftCommon Shares 50,000 $0.00 $0.00
Disclosure

SEC source: 0001628280-26-056653 · wk-form4_1786647701.xml · nonDerivative · entry 1

Hayden Michael R · CIK 0001352908 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 1,273,397

F1 · price: This transaction represents a charitable donation of 50,000 common shares made by Genworks 2 Consulting, Inc. on August 11, 2026.

F2 · ownership.direct: These shares are held by Genworks 2 Consulting, Inc. The Reporting Person's spouse has sole voting and investment power with respect to the shares held by Genworks 2 Consulting, Inc. The reporting person disclaims beneficial ownership of such securities, except to the extent of his indirect pecuniary interest, if any, therein.

Read SEC document
July 01, 2026 Filed Jul 6, 2026 22:20 UTC
Seely LynnDirector
GrantShare option (right to buy) · Derivative 152,207 $0.00 Strike: $7.85 $0.00
Disclosure

SEC source: 0001628280-26-047400 · wk-form4_1783376448.xml · derivative · entry 1

Seely Lynn · CIK 0001327111 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 152,207

Underlying: Common Shares · 152,207 shares

Expires 2036-07-01

F1 · derivative.exercise_date: The shares subject to such option vest and become exercisable annually in substantially equal installments over a three-year period, with the first tranche vested on July 1, 2027, subject to the Reporting Person's continuous service to the Issuer on each such date.

Read SEC document
July 01, 2026 Filed Jul 6, 2026 22:04 UTC GrantShare option (right to buy) · Derivative 152,207 $0.00 Strike: $7.85 $0.00
Disclosure

SEC source: 0001628280-26-047396 · wk-form4_1783375492.xml · derivative · entry 1

Sandor Victor · CIK 0001620368 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 152,207

Underlying: Common Shares · 152,207 shares

Expires 2036-07-01

F1 · derivative.exercise_date: The shares subject to such option vest and become exercisable annually in substantially equal installments over a three-year period, with the first tranche vested on July 1, 2027, subject to the Reporting Person's continuous service to the Issuer on each such date.

Read SEC document
June 11, 2026 Filed Jun 12, 2026 13:03 UTC GrantShare option (right to buy) · Derivative 111,701 $0.00 Strike: $5.27 $0.00
Disclosure

SEC source: 0001685889-26-000002 · wk-form4_1781283792.xml · derivative · entry 1

Quake Stephen · CIK 0001685889 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 306,633

Underlying: Common Shares · 111,701 shares

Expires 2036-06-11

F1 · derivative.exercise_date: The shares subject to such option vest and become exercisable at the 2027 Annual General Meeting, subject to the Reporting Person's continuous service to the Issuer on each such date.

Read SEC document
June 11, 2026 Filed Jun 12, 2026 17:04 UTC GrantShare option (right to buy) · Derivative 111,701 $0.00 Strike: $5.27 $0.00
Disclosure

SEC source: 0001628280-26-042739 · wk-form4_1781283845.xml · derivative · entry 1

Hayden Michael R · CIK 0001352908 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,011,544

Underlying: Common Shares · 111,701 shares

Expires 2036-06-11

F1 · derivative.exercise_date: The shares subject to such option vest and become exercisable at the 2027 Annual General Meeting, subject to the Reporting Person's continuous service to the Issuer on each such date.

Read SEC document
June 11, 2026 Filed Jun 12, 2026 17:02 UTC GrantShare option (right to buy) · Derivative 111,701 $0.00 Strike: $5.27 $0.00
Disclosure

SEC source: 0001834423-26-000006 · wk-form4_1781283746.xml · derivative · entry 1

Montalbano John S. · CIK 0001834423 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,141,544

Underlying: Common Shares · 111,701 shares

Expires 2036-06-11

F1 · derivative.exercise_date: The shares subject to such option vest and become exercisable at the 2027 Annual General Meeting, subject to the Reporting Person's continuous service to the Issuer on each such date.

Read SEC document
June 03, 2026 Filed Jun 3, 2026 18:23 UTC
Booth AndrewChief Financial Officer
Exercise / conversionShare option (right to buy) · Derivative 250,000 $0.00 Strike: $0.19 $0.00
Disclosure

SEC source: 0001834411-26-000006 · wk-form4_1780510993.xml · derivative · entry 3

Booth Andrew · CIK 0001834411 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,501,849

Underlying: Common Shares · 250,000 shares

Expires 2026-06-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The shares subject to such option vest and become exercisable annually in substantially equal installments over a six-year period, with the first tranche vested on June 15, 2017, subject to the Reporting Person's continuous service to the Issuer on each such date.

Read SEC document
June 03, 2026 Filed Jun 3, 2026 18:23 UTC
Booth AndrewChief Financial Officer
Exercise / conversionCommon Shares 250,000 $0.19 $47,500.00
Disclosure

SEC source: 0001834411-26-000006 · wk-form4_1780510993.xml · nonDerivative · entry 1

Booth Andrew · CIK 0001834411 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 445,600

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 14, 2026 Filed May 18, 2026 16:09 UTC PurchaseCommon Shares 20,000 $4.77 $95,400.00
Disclosure

SEC source: 0001834423-26-000004 · wk-form4_1779120582.xml · nonDerivative · entry 1

Montalbano John S. · CIK 0001834423 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 241,000

Read SEC document
February 27, 2026 Filed Feb 27, 2026 19:48 UTC
Booth AndrewChief Financial Officer
PurchaseCommon Shares 42,600 $3.42 $145,692.00
Disclosure

SEC source: 0001834411-26-000004 · wk-form4_1772221711.xml · nonDerivative · entry 1

Booth Andrew · CIK 0001834411 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 195,600

Read SEC document
February 27, 2026 Filed Mar 2, 2026 19:16 UTC PurchaseCommon Shares 38,000 $3.44 $130,720.00
Disclosure

SEC source: 0001834449-26-000004 · wk-form4_1772478998.xml · nonDerivative · entry 1

Thermopylae Holdings Ltd. · CIK 0001834449 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56,134,097

F1 · price: The price reported in Column 4 is a weighted-average price. These shares were acquired in multiple transactions at prices ranging from $3.42 to $3.45. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote.

Read SEC document
February 26, 2026 Filed Feb 27, 2026 21:20 UTC PurchaseCommon Shares 177,457 $3.27 $580,284.39
Disclosure

SEC source: 0001834449-26-000002 · wk-form4_1772227198.xml · nonDerivative · entry 1

Thermopylae Holdings Ltd. · CIK 0001834449 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56,096,097

F1 · price: The price reported in Column 4 is a weighted-average price. These shares were acquired in multiple transactions at prices ranging from $3.19 to $3.40. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote.

Read SEC document
January 01, 2026 Filed Jan 5, 2026 17:11 UTC
Booth AndrewChief Financial Officer
GrantShare option (right to buy) · Derivative 808,898 $0.00 Strike: $3.42 $0.00
Disclosure

SEC source: 0001834411-26-000002 · wk-form4_1767633111.xml · derivative · entry 1

Booth Andrew · CIK 0001834411 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,751,849

Underlying: Common Shares · 808,898 shares

Expires 2036-01-01

F1 · derivative.exercise_date: The shares subject to such option vest and become exercisable monthly in substantially equal installments over a four-year period, with the first tranche vested on January 1, 2027, subject to the Reporting Person's continuous service to the Issuer on each such date.

Read SEC document
January 01, 2026 Filed Jan 5, 2026 17:10 UTC
Hansen Carl L. G.Director · Chief Executive Officer · 10% owner
GrantShare option (right to buy) · Derivative 2,106,505 $0.00 Strike: $3.42 $0.00
Disclosure

SEC source: 0001834412-26-000002 · wk-form4_1767633053.xml · derivative · entry 1

Hansen Carl L. G. · CIK 0001834412 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,096,837

Underlying: Common Shares · 2,106,505 shares

Expires 2036-01-01

F1 · derivative.exercise_date: The shares subject to such option vest and become exercisable monthly in substantially equal installments over a four-year period, with the first tranche vested on January 1, 2027, subject to the Reporting Person's continuous service to the Issuer on each such date.

Read SEC document
January 01, 2026 Filed Jan 5, 2026 17:10 UTC
Stimart TrynChief Legal Officer
GrantShare option (right to buy) · Derivative 539,265 $0.00 Strike: $3.42 $0.00
Disclosure

SEC source: 0001834424-26-000002 · wk-form4_1767633019.xml · derivative · entry 1

Stimart Tryn · CIK 0001834424 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,646,012

Underlying: Common Shares · 539,265 shares

Expires 2036-01-01

F1 · derivative.exercise_date: The shares subject to such option vest and become exercisable monthly in substantially equal installments over a four-year period, with the first tranche vested on January 1, 2027, subject to the Reporting Person's continuous service to the Issuer on each such date.

Read SEC document
January 01, 2026 Filed Jan 5, 2026 17:08 UTC
Lecault VeroniqueDirector · Chief Technology Officer
GrantShare option (right to buy) · Derivative 539,265 $0.00 Strike: $3.42 $0.00
Disclosure

SEC source: 0001834418-26-000002 · wk-form4_1767632934.xml · derivative · entry 1

Lecault Veronique · CIK 0001834418 · Director · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,201,069

Underlying: Common Shares · 539,265 shares

Expires 2036-01-01

F1 · derivative.exercise_date: The shares subject to such option vest and become exercisable monthly in substantially equal installments over a four-year period, with the first tranche vested on January 1, 2027, subject to the Reporting Person's continuous service to the Issuer on each such date.

Read SEC document
December 18, 2025 Filed Dec 19, 2025 18:24 UTC GiftCommon Shares 225,000 $0.00 $0.00
Disclosure

SEC source: 0001834449-25-000004 · wk-form4_1766168642.xml · nonDerivative · entry 1

Thermopylae Holdings Ltd. · CIK 0001834449 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,918,640

F1 · price: This transaction represents a charitable donation of 225,000 common shares the reporting person donated on December 18, 2025.

Read SEC document
December 01, 2025 Filed Dec 19, 2025 14:46 UTC GrantShare option (right to buy) · Derivative 194,932 $0.00 Strike: $3.47 $0.00
Disclosure

SEC source: 0001685889-25-000008 · wk-form4_1766173569.xml · derivative · entry 1

Quake Stephen · CIK 0001685889 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 194,932

Underlying: Common Shares · 194,932 shares

Expires 2035-12-01

F1 · derivative.exercise_date: The shares subject to such option vest and become exercisable annually in substantially equal installments over a three-year period, with the first tranche vested on December 1, 2026, subject to the Reporting Person's continuous service to the Issuer on each such date.

Read SEC document
November 26, 2025 Filed Nov 26, 2025 19:58 UTC PurchaseCommon Shares 50,000 $3.57 $178,460.00
Disclosure

SEC source: 0001834423-25-000004 · wk-form4_1764187098.xml · nonDerivative · entry 1

Montalbano John S. · CIK 0001834423 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 221,000

Read SEC document
June 12, 2025 Filed Jun 16, 2025 21:30 UTC
Lo AndrewDirector
GrantShare option (right to buy) · Derivative 238,864 $0.00 Strike: $3.15 $0.00
Disclosure

SEC source: 0001628280-25-031646 · wk-form4_1750109427.xml · derivative · entry 1

Lo Andrew · CIK 0001679076 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 541,354

Underlying: Common Shares · 238,864 shares

Expires 2035-06-12

F1 · derivative.exercise_date: The shares subject to such option vest and become exercisable at the 2026 Annual General Meeting, subject to the Reporting Person's continuous service to the Issuer on each such date.

Read SEC document
June 12, 2025 Filed Jun 16, 2025 21:32 UTC GrantShare option (right to buy) · Derivative 238,864 $0.00 Strike: $3.15 $0.00
Disclosure

SEC source: 0001628280-25-031647 · wk-form4_1750109513.xml · derivative · entry 1

Montalbano John S. · CIK 0001834423 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,029,843

Underlying: Common Shares · 238,864 shares

Expires 2035-06-12

F1 · derivative.exercise_date: The shares subject to such option vest and become exercisable at the 2026 Annual General Meeting, subject to the Reporting Person's continuous service to the Issuer on each such date.

Read SEC document
June 12, 2025 Filed Jul 1, 2025 19:13 UTC GrantShare option (right to buy) · Derivative 238,864 $0.00 Strike: $3.15 $0.00
Disclosure

SEC source: 0001628280-25-033735 · wk-form4_1751397189.xml · derivative · entry 1

Hayden Michael R · CIK 0001352908 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 899,843

Underlying: Common Shares · 238,864 shares

Expires 2035-06-12

F1 · derivative.exercise_date: The shares subject to such option vest and become exercisable at the 2026 Annual General Meeting, subject to the Reporting Person's continuous service to the Issuer on each such date.

Read SEC document
March 11, 2025 Filed Mar 11, 2025 22:42 UTC PurchaseCommon Shares 343,631 $2.16 $742,242.96
Disclosure

SEC source: 0001628280-25-012154 · wk-form4_1741732971.xml · nonDerivative · entry 1

Thermopylae Holdings Ltd. · CIK 0001834449 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56,143,640

F1 · price: The price reported in Column 4 is a weighted-average price. These shares were acquired in multiple transactions at prices ranging from $2.12 to $2.23. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote.

Read SEC document
March 10, 2025 Filed Mar 10, 2025 21:11 UTC PurchaseCommon Shares 25,000 $2.30 $57,500.00
Disclosure

SEC source: 0001628280-25-011750 · wk-form4_1741641056.xml · nonDerivative · entry 1

Montalbano John S. · CIK 0001834423 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 171,000

Read SEC document
March 06, 2025 Filed Mar 7, 2025 20:32 UTC PurchaseCommon Shares 60,000 $2.34 $140,568.00
Disclosure

SEC source: 0001628280-25-011254 · wk-form4_1741379514.xml · nonDerivative · entry 1

Montalbano John S. · CIK 0001834423 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 146,000

Read SEC document
January 01, 2025 Filed Jan 3, 2025 20:44 UTC
Stimart TrynChief Legal Officer
GrantShare option (right to buy) · Derivative 832,033 $0.00 Strike: $2.93 $0.00
Disclosure

SEC source: 0001628280-25-000237 · wk-form4_1735937075.xml · derivative · entry 1

Stimart Tryn · CIK 0001834424 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,106,747

Underlying: Common Shares · 832,033 shares

Expires 2035-01-01

F1 · derivative.exercise_date: The shares subject to such option vest and become exercisable monthly in substantially equal installments over a four-year period, with the first tranche vested on January 1, 2026, subject to the Reporting Person's continuous service to the Issuer on each such date.

Read SEC document
January 01, 2025 Filed Jan 3, 2025 20:40 UTC
Lecault VeroniqueDirector · Chief Operating Officer
GrantShare option (right to buy) · Derivative 832,033 $0.00 Strike: $2.93 $0.00
Disclosure

SEC source: 0001628280-25-000235 · wk-form4_1735936840.xml · derivative · entry 1

Lecault Veronique · CIK 0001834418 · Director · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,661,804

Underlying: Common Shares · 832,033 shares

Expires 2035-01-01

F1 · derivative.exercise_date: The shares subject to such option vest and become exercisable monthly in substantially equal installments over a four-year period, with the first tranche vested on January 1, 2026, subject to the Reporting Person's continuous service to the Issuer on each such date.

Read SEC document
January 01, 2025 Filed Jan 3, 2025 20:37 UTC
Booth AndrewChief Financial Officer
GrantShare option (right to buy) · Derivative 1,352,054 $0.00 Strike: $2.93 $0.00
Disclosure

SEC source: 0001628280-25-000233 · wk-form4_1735936673.xml · derivative · entry 1

Booth Andrew · CIK 0001834411 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,942,951

Underlying: Common Shares · 1,352,054 shares

Expires 2035-01-01

F1 · derivative.exercise_date: The shares subject to such option vest and become exercisable monthly in substantially equal installments over a four-year period, with the first tranche vested on January 1, 2026, subject to the Reporting Person's continuous service to the Issuer on each such date.

Read SEC document
January 01, 2025 Filed Jan 3, 2025 20:36 UTC
Hansen Carl L. G.Director · Chief Executive Officer · 10% owner
GrantShare option (right to buy) · Derivative 2,730,109 $0.00 Strike: $2.93 $0.00
Disclosure

SEC source: 0001628280-25-000232 · wk-form4_1735936582.xml · derivative · entry 1

Hansen Carl L. G. · CIK 0001834412 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,990,332

Underlying: Common Shares · 2,730,109 shares

Expires 2035-01-01

F1 · derivative.exercise_date: The shares subject to such option vest and become exercisable monthly in substantially equal installments over a four-year period, with the first tranche vested on January 1, 2026, subject to the Reporting Person's continuous service to the Issuer on each such date

Read SEC document
December 04, 2024 Filed Dec 5, 2024 21:47 UTC GiftCommon Shares 286,000 $0.00 $0.00
Disclosure

SEC source: 0001628280-24-050097 · wk-form4_1733435235.xml · nonDerivative · entry 1

Thermopylae Holdings Ltd. · CIK 0001834449 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,800,009

F1 · price: This transaction represents a charitable donation of 286,000 common shares the reporting person donated on December 4, 2024.

Read SEC document
November 25, 2024 Filed Nov 26, 2024 22:38 UTC
Hansen Carl L. G.Director · Chief Executive Officer · 10% owner
Exercise / conversionShare option (right to buy) · Derivative 56,125 $0.00 Strike: $2.70 $0.00
Disclosure

SEC source: 0001628280-24-049327 · wk-form4_1732660694.xml · derivative · entry 3

Hansen Carl L. G. · CIK 0001834412 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,260,223

Underlying: Common Shares · 56,125 shares

Expires 2030-11-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The shares subject to such option vest and become exercisable quarterly in substantially equal installments over a four-year period, with the first tranche vested on November 18, 2021, subject to the Reporting Person's continuous service to the Issuer on each such date.

Read SEC document
November 25, 2024 Filed Nov 26, 2024 22:38 UTC
Hansen Carl L. G.Director · Chief Executive Officer · 10% owner
Exercise / conversionCommon Shares 56,125 $2.70 $151,537.50
Disclosure

SEC source: 0001628280-24-049327 · wk-form4_1732660694.xml · nonDerivative · entry 1

Hansen Carl L. G. · CIK 0001834412 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 898,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 20, 2024 Filed Sep 24, 2024 20:09 UTC
Hansen Carl L. G.Director · Chief Executive Officer · 10% owner
Exercise / conversionShare option (right to buy) · Derivative 56,125 $0.00 Strike: $2.70 $0.00
Disclosure

SEC source: 0001628280-24-041217 · wk-form4_1727208568.xml · derivative · entry 3

Hansen Carl L. G. · CIK 0001834412 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,316,348

Underlying: Common Shares · 56,125 shares

Expires 2030-11-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The shares subject to such option vest and become exercisable quarterly in substantially equal installments over a four-year period, with the first tranche vested on November 18, 2021, subject to the Reporting Person's continuous service to the Issuer on each such date.

Read SEC document
September 20, 2024 Filed Sep 24, 2024 20:09 UTC
Hansen Carl L. G.Director · Chief Executive Officer · 10% owner
Exercise / conversionCommon Shares 56,125 $2.70 $151,537.50
Disclosure

SEC source: 0001628280-24-041217 · wk-form4_1727208568.xml · nonDerivative · entry 1

Hansen Carl L. G. · CIK 0001834412 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 841,875

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 29, 2024 Filed Aug 29, 2024 20:35 UTC PurchaseCommon Shares 283,516 $2.61 $739,976.76
Disclosure

SEC source: 0001628280-24-038829 · wk-form4_1724963720.xml · nonDerivative · entry 1

Thermopylae Holdings Ltd. · CIK 0001834449 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56,086,009

F1 · price: The price reported in Column 4 is a weighted-average price. These shares were acquired in multiple transactions at prices ranging from $2.55 to $2.67. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote.

Read SEC document
June 21, 2024 Filed Jun 24, 2024 22:30 UTC GrantShare option (right to buy) · Derivative 163,934 $0.00 Strike: $2.94 $0.00
Disclosure

SEC source: 0001628280-24-029673 · wk-form4_1719268228.xml · derivative · entry 1

Hayden Michael R · CIK 0001352908 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 660,979

Underlying: Common Shares · 163,934 shares

Expires 2034-06-21

Read SEC document
June 21, 2024 Filed Jun 24, 2024 22:19 UTC
Lo AndrewDirector
GrantShare option (right to buy) · Derivative 163,934 $0.00 Strike: $2.94 $0.00
Disclosure

SEC source: 0001628280-24-029668 · wk-form4_1719267587.xml · derivative · entry 1

Lo Andrew · CIK 0001679076 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 302,490

Underlying: Common Shares · 163,934 shares

Expires 2034-06-21

Read SEC document
June 21, 2024 Filed Jun 24, 2024 22:38 UTC
Lecault VeroniqueDirector · Chief Operating Officer
Exercise / conversionShare option (right to buy) · Derivative 83,334 $0.00 Strike: $0.19 $0.00
Disclosure

SEC source: 0001628280-24-029675 · wk-form4_1719268705.xml · derivative · entry 5

Lecault Veronique · CIK 0001834418 · Director · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,829,771

Underlying: Common Shares · 83,334 shares

Expires 2027-03-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The shares subject to such option vest and become exercisable annually in substantially equal installments over a six-year period, with the first tranche vested on November 8, 2017, subject to the Reporting Person's continuous service to the Issuer on each such date.

Read SEC document
June 21, 2024 Filed Jun 24, 2024 22:38 UTC
Lecault VeroniqueDirector · Chief Operating Officer
Exercise / conversionCommon Shares 83,334 $0.19 $15,666.79
Disclosure

SEC source: 0001628280-24-029675 · wk-form4_1719268705.xml · nonDerivative · entry 1

Lecault Veronique · CIK 0001834418 · Director · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,123,456

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 21, 2024 Filed Jun 24, 2024 22:15 UTC GrantShare option (right to buy) · Derivative 163,934 $0.00 Strike: $2.94 $0.00
Disclosure

SEC source: 0001628280-24-029666 · wk-form4_1719267313.xml · derivative · entry 1

Montalbano John S. · CIK 0001834423 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 790,979

Underlying: Common Shares · 163,934 shares

Expires 2034-06-21

Read SEC document
May 31, 2024 Filed Jun 3, 2024 20:21 UTC
Hansen Carl L. G.Director · Chief Executive Officer · 10% owner
Exercise / conversionShare option (right to buy) · Derivative 56,125 $0.00 Strike: $2.70 $0.00
Disclosure

SEC source: 0001628280-24-026338 · wk-form4_1717446060.xml · derivative · entry 3

Hansen Carl L. G. · CIK 0001834412 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,372,473

Underlying: Common Shares · 56,125 shares

Expires 2030-11-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The shares subject to such option vest and become exercisable quarterly in substantially equal installments over a four-year period, with the first tranche vested on November 18, 2021, subject to the Reporting Person's continuous service to the Issuer on each such date.

Read SEC document
May 31, 2024 Filed Jun 3, 2024 20:21 UTC
Hansen Carl L. G.Director · Chief Executive Officer · 10% owner
Exercise / conversionCommon Shares 56,125 $2.70 $151,537.50
Disclosure

SEC source: 0001628280-24-026338 · wk-form4_1717446060.xml · nonDerivative · entry 1

Hansen Carl L. G. · CIK 0001834412 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 785,750

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 26, 2024 Filed Feb 27, 2024 19:12 UTC
Hansen Carl L. G.Director · Chief Executive Officer · 10% owner
Exercise / conversionShare option (right to buy) · Derivative 56,125 $0.00 Strike: $2.70 $0.00
Disclosure

SEC source: 0001703057-24-000026 · wk-form4_1709061178.xml · derivative · entry 3

Hansen Carl L. G. · CIK 0001834412 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,428,598

Underlying: Common Shares · 56,125 shares

Expires 2030-11-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The shares subject to such option vest and become exercisable quarterly in substantially equal installments over a four-year period, with the first tranche vested on November 18, 2021, subject to the Reporting Person's continuous service to the Issuer on each such date.

Read SEC document
February 26, 2024 Filed Feb 27, 2024 19:12 UTC
Hansen Carl L. G.Director · Chief Executive Officer · 10% owner
Exercise / conversionCommon Shares 56,125 $2.70 $151,537.50
Disclosure

SEC source: 0001703057-24-000026 · wk-form4_1709061178.xml · nonDerivative · entry 1

Hansen Carl L. G. · CIK 0001834412 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 729,625

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 14, 2024 Filed Jan 16, 2024 23:23 UTC
Lecault VeroniqueDirector · Chief Operating Officer
GrantShare option (right to buy) · Derivative 770,416 $0.00 Strike: $5.39 $0.00
Disclosure

SEC source: 0001703057-24-000008 · wk-form4_1705447421.xml · derivative · entry 1

Lecault Veronique · CIK 0001834418 · Director · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,913,105

Underlying: Common Shares · 770,416 shares

Expires 2034-01-14

F1 · derivative.exercise_date: The shares subject to such option vest and become exercisable monthly in substantially equal installments over a four-year period, with the first tranche vested on January 14, 2025, subject to the Reporting Person's continuous service to the Issuer on each such date.

Read SEC document
January 14, 2024 Filed Jan 16, 2024 23:21 UTC
Stimart TrynChief Legal Officer
GrantShare option (right to buy) · Derivative 616,333 $0.00 Strike: $5.39 $0.00
Disclosure

SEC source: 0001703057-24-000006 · wk-form4_1705447284.xml · derivative · entry 1

Stimart Tryn · CIK 0001834424 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,274,714

Underlying: Common Shares · 616,333 shares

Expires 2034-01-14

F1 · derivative.exercise_date: The shares subject to such option vest and become exercisable monthly in substantially equal installments over a four-year period, with the first tranche vested on January 14, 2025, subject to the Reporting Person's continuous service to the Issuer on each such date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.